The value of clinical trial research is projected to exceed $78 billion by 2030. Clinical trial digitalization can counter negative reporting bias and improve the integrity of trial results. Real-world data (RWD) relates to patient health status and care delivery, while real-world evidence (RWE) aggregates and transforms RWD to inform clinical settings and enhance patient outcomes.
